BMJ Global Health (Jul 2022)

Equity assessment of childhood immunisation at national and subnational levels in Myanmar: a benefit incidence analysis

  • Osondu Ogbuoji,
  • Wenhui Mao,
  • Thazin La,
  • Ashwini Sunil Deshpande,
  • Zin Mar Win,
  • Tom Traill,
  • Zarni Lynn Kyaw,
  • Khaing Thandar Hnin,
  • Phway Thinzar Chit

DOI
https://doi.org/10.1136/bmjgh-2021-007800
Journal volume & issue
Vol. 7, no. 7

Abstract

Read online

Introduction Myanmar, a conflict-affected geographically and ethnically diverse lower middle-income country, was in the donor transition phase for health prior to the political unrest of the last year. This study analyses the distribution of benefit and utilisation of basic childhood vaccinations from the highly donor-dependent Expanded Program on Immunization for populations of different socioeconomic status (SES).Methods We conducted a benefit incidence analysis with decomposition analysis to assess the equity of benefit. We used basic childhood immunisations—BCG, measles, diphtheria, pertussis and tetanus (DPT)/pentavalent, oral polio vaccine (OPV) and full vaccination—as measurements for healthcare use. Childhood immunisation data were collected from Myanmar Demographic and Health Survey. Cost of vaccines was obtained from UNICEF document and ‘Immunization Delivery Cost Catalogue’ and adjusted with regional cost variations. We reported Concentration Index (CI) and Achievement Index (AI) by SES, including wealth quintiles, maternal education and across geographic areas.Results Nationally, better-off households disproportionately used more services from the programme (CI–Wealth Index (CI-WI) for BCG, measles, DPT/pentavalent, OPV and full immunisation: 0.032, 0.051, 0.120, 0.091 and 0.137, respectively). Benefits had a pro-poor distribution for BCG but a less pro-rich distribution than utilisation for all other vaccines (CI-WI: −0.004, 0.019, 0.092, 0.045 and 0.106, respectively). Urban regions had a more pro-rich distribution of benefit than that in rural areas, where BCG and measles had a pro-poor distribution. Subnational analysis found significant heterogeneity: benefit was less equitably distributed, and AI was lower in conflict-affected states than in government-controlled areas. The major contributors to vaccine inequality were SES, antenatal care visits and paternal education.Conclusion Donors, national government and regional government should better plan to maintain vaccine coverage while improving equity of vaccine services, especially for children of lower SES, mothers with less antenatal care visits and lower paternal education living in conflicted-affected remote regions.